SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Karpov Y)
 

Sökning: WFRF:(Karpov Y) > (2005-2009) > Perindopril/indapam...

Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study

Dahlöf, Björn, 1953 (författare)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
Gosse, P. (författare)
Gueret, P. (författare)
visa fler...
Dubourg, O. (författare)
de Simone, G. (författare)
Schmieder, R. (författare)
Karpov, Y. (författare)
Garcia-Puig, J. (författare)
Matos, L. (författare)
De Leeuw, P. W. (författare)
Degaute, J. P. (författare)
Magometschnigg, D. (författare)
visa färre...
 (creator_code:org_t)
2005
2005
Engelska.
Ingår i: J Hypertens. - 0263-6352. ; 23:11, s. 2063-70
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • OBJECTIVE: Few data are available comparing the effects of monotherapy and combination therapy on target organ damage. The PICXEL study compared the efficacy of a strategy based on first-line combination with perindopril/indapamide versus monotherapy with enalapril in reducing left ventricular hypertrophy (LVH) in hypertensive patients. METHODS: In this 1-year multicentre randomized double-blind study, patients received an increasing dosage of perindopril/indapamide (n = 284) or enalapril (n = 272). Changes in blood pressure and echocardiographic measures of LVH were assessed from baseline to the end of treatment. Reading of the echocardiograms was central and blinded for therapy, patient and sequence. RESULTS: Systolic and diastolic blood pressure decreased significantly more in the perindopril/indapamide than in the enalapril group (P < 0.0001 and P = 0.003). The left ventricular mass index decreased by 13.6 +/- 23.9 g/m(2) (mean +/- SD) with perindopril/indapamide (P < 0.0001) and 3.9 +/- 23.9 g/m(2) with enalapril (P < 0.005); these decreases were significantly different (P < 0.0001). The left ventricular internal diameter, posterior and interventricular septal wall thickness decreased significantly with perindopril/indapamide (P < or = 0.0001); the interventricular septal wall thickness decreased significantly with enalapril (P < 0.001). Both treatments were well tolerated. CONCLUSION: A strategy based on first-line combination with perindopril/indapamide achieved better blood pressure decrease with a significantly greater degree of LVH reduction than a strategy based on monotherapy with enalapril in hypertensive patients with LVH.

Nyckelord

Adult
Aged
Antihypertensive Agents/adverse effects/*therapeutic use
Blood Pressure/*drug effects
Double-Blind Method
Drug Therapy
Combination
Echocardiography
Female
Heart Ventricles/physiopathology/ultrasonography
Humans
Hypertension/drug therapy/physiopathology
Hypertrophy
Left Ventricular/*drug therapy/physiopathology
Indapamide/adverse effects/*therapeutic use
Male
Middle Aged
Perindopril/adverse effects/*therapeutic use
Potassium/blood
Regression Analysis
Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy